IRS Issues Final Rule Implementing Medical Device Excise Tax
The Internal Revenue Service released a
implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.Related Resources
Webcast
In part two of the FDA Unique Device Identification (UDI) Unit of Use (UOU) webcast series, we cover the FDA definition of the term, Unit of Use.
Case Studies
WORK GROUP TITLE:
UDI Capture Work Group
CASE STUDY PARTICIPANTS:
Case Studies
WORK GROUP TITLE:
UDI Capture Work Group
CASE STUDY PARTICIPANTS:
Toolkits/Methodology
Case Studies
WORK GROUP TITLE:
UDI Capture Work Group
CASE STUDY PARTICIPANTS:
Case Studies
WORK GROUP TITLE:
UDI Capture Work Group
CASE STUDY PARTICIPANTS:
Pagination
- First page
- Previous page
- More previous pages available
- Page 13
- Page 14
- Page 15
- Page 16
- Current page 17
- Page 18
- Page 19
- Page 20
- Page 21
- Next page
- Last page